COV — Covalon Technologies Share Price
0.000.00%
Last trade - 00:00- CA$28.37m
- CA$21.45m
- CA$26.60m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.61 | ||
| Price to Tang. Book | 1.73 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -27.34% | ||
| Return on Equity | -23.98% | ||
| Operating Margin | -20.08% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 34 | 13.51 | 19.56 | 18.15 | 26.6 | n/a | n/a | -0.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.
Directors
- Amir Boloor NEC
- Brian Pedlar PRE
- Jason Gorel CFO
- Gerry Arambula CEX
- Simon Smith CEX
- Hector Padilla VPR
- Martin Goldfarb DRC
- Abe Schwartz DRC
- Joseph Cordiano IND
- Ronald Smith IND
- Last Annual
- September 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 28th, 2004
- Public Since
- September 3rd, 2004
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 24,669,577
- Address
- 1660 Tech Avenue, Unit 5, MISSISSAUGA, L4W 5S7
- Web
- https://covalon.com/
- Phone
- +1 9055688400
- Contact
- Brent Ashton
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for COV
Q3 2024 Covalon Technologies Ltd Earnings Release
Similar to COV
Arch Biopartners
TSX Venture Exchange
biOasis Technologies
TSX Venture Exchange
Ceapro
TSX Venture Exchange
Hemostemix
TSX Venture Exchange
Innovotech
TSX Venture Exchange
FAQ
What is the Covalon Technologies share price?
As of Today at 19:06 UTC, shares in Covalon Technologies are trading at CA$1.15. This share price information is delayed by 15 minutes.
How has the Covalon Technologies share price performed this year?
Shares in Covalon Technologies last closed at CA$1.15 and the price had moved by -45.5% over the past 365 days. In terms of relative price strength the Covalon Technologies share price has underperformed the Toronto Stock Exchange 300 Composite Index by -48.28% over the past year.
What are the analyst and broker recommendations for Covalon Technologies?
There is no consensus recommendation for this security.
What is the Covalon Technologies dividend yield?
Covalon Technologies does not currently pay a dividend.
Does Covalon Technologies pay a dividend?
Covalon Technologies does not currently pay a dividend.
When does Covalon Technologies next pay dividends?
Covalon Technologies does not currently pay a dividend.
How do I buy Covalon Technologies shares?
To buy shares in Covalon Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Covalon Technologies?
As of the previous close price of CA$1.15, shares in Covalon Technologies had a market capitalisation of CA$28.37m.
Where are Covalon Technologies shares listed?
Here are the trading details for Covalon Technologies:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: COV
What kind of share is Covalon Technologies?
Based on an overall assessment of its quality, value and momentum Covalon Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Covalon Technologies share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Covalon Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Covalon Technologies. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -33.89%.
As of the last closing price of CA$1.15, shares in Covalon Technologies were trading -31.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Covalon Technologies PE Ratio?
The Covalon Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Covalon Technologies?
Covalon Technologies' management team is headed by:
- Amir Boloor - NEC
- Brian Pedlar - PRE
- Jason Gorel - CFO
- Gerry Arambula - CEX
- Simon Smith - CEX
- Hector Padilla - VPR
- Martin Goldfarb - DRC
- Abe Schwartz - DRC
- Joseph Cordiano - IND
- Ronald Smith - IND